Parad RB - Search Results

1

Differences in clinical and laboratory biomarkers for short and long-term respiratory outcomes in preterm neonates.

Parad RB, Breeze JL, Terrin N, Rogers LK, Salafia CM, Greenough A, Davis JM. Parad RB, et al. Pediatr Pulmonol. 2021 Dec;56(12):3847-3856. doi: 10.1002/ppul.25630. Epub 2021 Aug 26. Pediatr Pulmonol. 2021. PMID: 34437765 Free PMC article.

2

The role of recombinant human CC10 in the prevention of chronic pulmonary insufficiency of prematurity.

Davis JM, Pilon AL, Shenberger J, Breeze JL, Terrin N, Mazela J, Gulczynska E, Lauterbach R, Parad R. Davis JM, et al. Pediatr Res. 2019 Aug;86(2):254-260. doi: 10.1038/s41390-019-0419-3. Epub 2019 May 13. Pediatr Res. 2019. PMID: 31086287 Free PMC article. Clinical Trial.

3

Reduction of retinopathy of prematurity in extremely low gestational age newborns treated with recombinant human Cu/Zn superoxide dismutase.

Parad RB, Allred EN, Rosenfeld WN, Davis JM. Parad RB, et al. Neonatology. 2012;102(2):139-44. doi: 10.1159/000336639. Epub 2012 Jun 15. Neonatology. 2012. PMID: 22710821 Clinical Trial.

4

Prediction of respiratory outcome in extremely low gestational age infants.

Parad RB, Davis JM, Lo J, Thomas M, Marlow N, Calvert S, Peacock JL, Greenough A. Parad RB, et al. Neonatology. 2015;107(4):241-8. doi: 10.1159/000369878. Epub 2015 Mar 3. Neonatology. 2015. PMID: 25765705 Free PMC article. Clinical Trial.

5

Economic evaluation of recombinant human copper zinc superoxide dismutase administered at birth to premature infants.

McBride JA, Parad RB, Davis JM, Zheng Z, Zupancic JA; North America Superoxide Dismutase Study Group. McBride JA, et al. Among authors: parad rb. J Perinatol. 2009 May;29(5):364-71. doi: 10.1038/jp.2008.225. Epub 2009 Feb 19. J Perinatol. 2009. PMID: 19225525

6

Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase.

Davis JM, Parad RB, Michele T, Allred E, Price A, Rosenfeld W; North American Recombinant Human CuZnSOD Study Group. Davis JM, et al. Among authors: parad rb. Pediatrics. 2003 Mar;111(3):469-76. doi: 10.1542/peds.111.3.469. Pediatrics. 2003. PMID: 12612223 Clinical Trial.

7

Long-term follow-up of premature infants treated with prophylactic, intratracheal recombinant human CuZn superoxide dismutase.

Davis JM, Richter SE, Biswas S, Rosenfeld WN, Parton L, Gewolb IH, Parad R, Carlo W, Couser RJ, Baumgart S, Atluru V, Salerno L, Kassem N. Davis JM, et al. J Perinatol. 2000 Jun;20(4):213-6. doi: 10.1038/sj.jp.7200363. J Perinatol. 2000. PMID: 10879331

8

Urine Proteomics for Noninvasive Monitoring of Biomarkers in Bronchopulmonary Dysplasia.

Ahmed S, Odumade OA, van Zalm P, Smolen KK, Fujimura K, Muntel J, Rotunno MS, Winston AB, Steen JA, Parad RB, Van Marter LJ, Kourembanas S, Steen H. Ahmed S, et al. Among authors: parad rb. Neonatology. 2022;119(2):193-203. doi: 10.1159/000520680. Epub 2022 Jan 24. Neonatology. 2022. PMID: 35073553 Free PMC article.

9

An oversight regarding the club cell?

Parad RB. Parad RB. Pediatr Pulmonol. 2022 Sep;57(9):2252. doi: 10.1002/ppul.25970. Epub 2022 May 21. Pediatr Pulmonol. 2022. PMID: 35560815 No abstract available.

10

Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity.

Levesque BM, Kalish LA, Winston AB, Parad RB, Hernandez-Diaz S, Phillips M, Zolit A, Morey J, Gupta M, Mammoto A, Ingber DE, Van Marter LJ. Levesque BM, et al. Among authors: parad rb. Neonatology. 2013;104(1):56-64. doi: 10.1159/000351040. Epub 2013 May 24. Neonatology. 2013. PMID: 23711562

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

102 results

Search Page

Filters